RVMD
Revolution Medicines Inc Earnings
$36.76
Earnings Summary
Revenue | $0Mn |
Net Profits | $-194.57Mn |
Net Profit Margins | -Inf% |
Revolution Medicines Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2024. On a quarterly growth basis, Revolution Medicines Inc has generated NaN% jump in its revenue since last 3-months.
Revolution Medicines Inc’s net profit fell -20.45% since last year same period to $-194.57Mn in the Q4 2024. On a quarterly growth basis, Revolution Medicines Inc has generated -24.49% fall in its net profits since last 3-months.
Revolution Medicines Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2024. On a quarterly growth basis, Revolution Medicines Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.75 |
EPS Estimate Current Year | -0.75 |
Revolution Medicines Inc’s earning per share (EPS) estimates for the current quarter stand at -0.75 - a 22.24% jump from last quarter’s estimates.
Revolution Medicines Inc’s earning per share (EPS) estimates for the current year stand at -0.75.
Key Ratios
Earning Per Share (EPS) | -1.12 |
Revolution Medicines Inc’s earning per share (EPS) jumped 1.75% since last year same period to -1.12 in the Q4 2024. This indicates that the Revolution Medicines Inc has generated 1.75% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-08 | -0.75 | -0.7 | 6.67% |
2025-02-26 | -0.96 | -1.12 | -16.12% |
2024-11-06 | -0.89 | -0.94 | -5.62% |
2024-08-07 | -0.77 | -0.81 | -5.19% |
